Skip to main content

Table 4 Antibacterial activity of SeNPs synthesized by A. quadrilineatus, A. ochraceus, A. terreus, and F. equiseti against different Gram-positive and Gram-negative human pathogenic bacterial strains

From: Harnessing endophytic fungi for biosynthesis of selenium nanoparticles and exploring their bioactivities

SeNPs concentration

(µg mL− 1)

Diameter of inhibition zone (mm)

E. coli

B. cereus

B. subtilis

S. aureus

P. aeruginosa

K. pneumoniae

A. quadrilineatus

0.0 (C)

0.00e

0.00e

0.00e

0.00d

0.00d

0.00d

31.25

0.00e

0.00e

0.00e

0.00d

0.00d

0.00d

62.50

18.00 ± 1.00d

0.00e

0.00e

0.00d

0.00d

0.00d

125

25.67 ± 0.58c

12.67 ± 0.58d

15.00 ± 1.00d

15.33 ± 0.58c

0.00d

0.00d

250

36.67 ± 1.54b

27.00 ± 1.00c

24.67 ± 1.54c

28.00 ± 1.00c

17.67 ± 0.58c

17.33 ± 2.08c

500

52.33 ± 2.08a

35.67 ± 0.58b

33.00 ± 1.00b

43.33 ± 1.54b

26.00 ± 1.00b

27.00 ± 1.00b

1000

55.00 ± 2.00a

43.33 ± 2.08a

40.00 ± 2.00a

54.00 ± 2.00a

35.33 ± 1.54a

38.00 ± 1.00a

A. ochraceus

0.0 (C)

0.00e

0.00e

0.00e

0.00d

0.00d

0.00d

31.25

0.00e

0.00e

0.00e

0.00d

0.00d

0.00d

62.50

17.33 ± 2.00d

0.00e

0.00e

0.00e

0.00d

0.00d

125

23.00 ± 1.00d

16.33 ± 0.58d

11.33 ± 1.54d

17.33 ± 0.58d

0.00d

0.00d

250

34.00 ± 1.00c

24.00 ± 1.00c

18.00 ± 1.00c

26.00 ± 1.00c

11.67 ± 2.08c

11.00 ± 1.00c

500

42.00 ± 1.00b

31.67 ± 2.08b

24.33 ± 0.58b

32.00 ± 1.00b

17.33 ± 0.58b

17.33 ± 0.58b

1000

49.67 ± 0.58a

39.67 ± 1.54a

30.67 ± 2.08a

38.67 ± 2.08a

24.00 ± 1.00a

25.00 ± 2.08a

A. terreus

0.0 (C)

0.00d

0.00d

0.00c

0.00c

0.00c

0.00c

31.25

0.00d

0.00d

0.00c

0.00c

0.00c

0.00c

62.50

0.00d

0.00d

0.00c

0.00c

0.00c

0.00c

125

0.00d

0.00d

0.00c

0.00c

0.00c

0.00c

250

14.67 ± 0.68c

14.67 ± 2.08c

0.00c

0.00c

0.00c

0.00c

500

22.00 ± 1.00b

23.00 ± 2.00b

17.67 ± 2.08b

18.33 ± 1.54b

13.33 ± 2.08b

14.67 ± 1.54b

1000

31.33 ± 2.08a

32.33 ± 1.00a

27.00 ± 1.00a

35.00 ± 2.00a

21.00 ± 1.00a

22.00 ± 2.08a

F. equiseti

0.0 (C)

0.00e

0.00e

0.00e

0.00e

0.00e

0.00e

31.25

0.00e

0.00e

0.00e

0.00e

0.00e

0.00e

62.50

0.00e

0.00e

0.00e

0.00e

0.00c

0.00e

125

0.00e

0.00e

0.00e

0.00e

0.00c

0.00c

250

14.00 ± 1.00d

13.67 ± 0.58d

0.00e

0.00e

0.00c

0.00e

500

21.67 ± 1.54d

19.67 ± 2.08d

16.00 ± 2.00b

18.67 ± 1.54b

15.00 ± 1.00b

12.33 ± 2.08b

1000

30.00 ± 2.00d

27.00 ± 1.00d

25.00 ± 1.00a

26.33 ± 2.08a

23.00 ± 1.00a

18.33 ± 1.54a

Amoxicillin/Clavulanic acid

18.33 ± 2.08

16.67 ± 0.58

17.00 ± 2.00

11.67 ± 1.54

10.00 ± 2.00

13.33 ± 1.54

  1. Amoxicillin/Azithromycin was used at a concentration of 100 µg mL− 1. Calculated mean is for triplicate measurements from three independent experiments ± SD, a − eMeans with different superscripts in the same column for each fungal strain’s nanoparticle are considered statistically different (LSD test, P ≤ 0.05)